Filter by: patients

Treatments Reported by Patients with MS (Multiple Sclerosis)

41.1% of the 26,256 patients with MS (Multiple Sclerosis) report taking at least one of these treatments to modify their disease or manage its symptoms.

Treatment # Patients
Glatiramer acetate (Copaxone) 3345 13% Glatiramer acetate (Copaxone): 13%
Baclofen (Mylan Baclofen, Miorel...) 2395 9% Baclofen (Mylan Baclofen, Miorel...): 9%
Interferon beta-1a SubQ injection (Rebif) 1816 7% Interferon beta-1a SubQ injection (Rebif): 7%
Interferon beta-1a IM Injection (Avonex, Avonex Prefilled Syringe) 1493 6% Interferon beta-1a IM Injection (Avonex, Avonex Prefilled Syringe): 6%
Natalizumab (Tysabri, Antegren) 1347 5% Natalizumab (Tysabri, Antegren): 5%
Modafinil (Provigil, Alertec...) 1280 5% Modafinil (Provigil, Alertec...): 5%
Interferon beta-1b SubQ Injection (Betaseron, Betaferon...) 980 4% Interferon beta-1b SubQ Injection (Betaseron, Betaferon...): 4%
Dalfampridine (4-AP extended release) (Ampyra) 672 3% Dalfampridine (4-AP extended release) (Ampyra): 3%
Fingolimod (Gilenya) 250 1% Fingolimod (Gilenya): 1%
Mitoxantrone (Novantrone) 69 0% Mitoxantrone (Novantrone): 0%

Community Treatment Reports

Click on a treatment to see what patients with MS (Multiple Sclerosis) have to say about side-effects, efficacy, advice, burden, dosages and cost of any treatment they're taking for any condition.